You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Rituximab in Relapsing and Progressive Forms of Multiple Sclerosis: A Systematic Review
|
|---|---|
| Published in |
PLOS ONE, July 2013
|
| DOI | 10.1371/journal.pone.0066308 |
| Pubmed ID | |
| Authors |
Tamara Castillo-Trivino, Dejana Braithwaite, Peter Bacchetti, Emmanuelle Waubant |
| Abstract |
Rituximab is an anti-CD20 monoclonal antibody approved for non Hodgkin lymphoma and rheumatoid arthritis. It is being considered for the treatment of MS. |
X Demographics
The data shown below were collected from the profiles of 11 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 6 | 55% |
| Malaysia | 1 | 9% |
| Spain | 1 | 9% |
| Unknown | 3 | 27% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 8 | 73% |
| Scientists | 2 | 18% |
| Practitioners (doctors, other healthcare professionals) | 1 | 9% |
Mendeley readers
The data shown below were compiled from readership statistics for 194 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 2 | 1% |
| Denmark | 2 | 1% |
| South Africa | 1 | <1% |
| Brazil | 1 | <1% |
| Finland | 1 | <1% |
| Unknown | 187 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Ph. D. Student | 26 | 13% |
| Student > Master | 26 | 13% |
| Researcher | 25 | 13% |
| Student > Bachelor | 22 | 11% |
| Other | 18 | 9% |
| Other | 46 | 24% |
| Unknown | 31 | 16% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 83 | 43% |
| Agricultural and Biological Sciences | 18 | 9% |
| Biochemistry, Genetics and Molecular Biology | 12 | 6% |
| Neuroscience | 12 | 6% |
| Immunology and Microbiology | 6 | 3% |
| Other | 21 | 11% |
| Unknown | 42 | 22% |
Attention Score in Context
This research output has an Altmetric Attention Score of 19. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 November 2023.
All research outputs
#1,915,378
of 25,436,226 outputs
Outputs from PLOS ONE
#23,385
of 221,600 outputs
Outputs of similar age
#15,946
of 206,527 outputs
Outputs of similar age from PLOS ONE
#598
of 4,809 outputs
Altmetric has tracked 25,436,226 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 92nd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 221,600 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.7. This one has done well, scoring higher than 89% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 206,527 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 4,809 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 87% of its contemporaries.